Mohammad Farhan Ali's research while affiliated with Jamia Millia Islamia and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (3)
Neuroserpin (NS) is an inhibitory protein of serpin super family, its shutter region variants have high propensity to aggregate leading to pathological disorders like familial encephalopathy with NS inclusion bodies (FENIB). Helix F and β-sheet A of NS participate in the tissue plasminogen activator (tPA) inhibition but the mechanism is not yet com...
Neuroserpin (NS) is predominantly expressed in brain and inhibits tissue-type plasminogen activator (tPA) with implications in brain development and memory. Nature of conformational change in pathological variants in strand 6B and helix B of NS that cause a relatively mild to severe epilepsy (and/or dementia) remains largely elusive. MD simulation...
Pro-coagulant, anti-coagulant and fibrinolytic pathways are responsible for maintaining haemostatic balance under physiological conditions. Any deviation from these pathways would result in hypercoagulability leading to life threatening diseases like myocardial infarction, stroke, portal vein thrombosis, deep vein thrombosis (DVT) and pulmonary emb...
Citations
... Undigested non-methylated daughter plasmid DNA was used for transformation in DH5α strains of E. coli for plasmid amplification [44]. ...
... Helix F has been predicted to unfold at both N and C terminal end during RCL transition, but another hypothesis predicted helix F to be displaced and rearranged after RCL transition [12,[31][32]. Variants in the helix F, strand 6B, helix B and strand 2A in the shutter regions show appreciable increase in the polymerization, however in these variants inhibitory activity against tPA is largely maintained [13,44,45]. Strand 1A is away from the RCL insertion site however it is connected to the helix F through a loop and its N-terminal end connects to s2A ...
... Heparin is a well-known regulator of the coagulation cascade that is also a potent inhibitor of angiogenesis [708] (see Figure 12). Heparin, therefore, directly modulates the coagulation cascade and is an excellent anticoagulant in diseases where hypercoagulation is prevalent. ...